|
Jul 16
|
United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025
|
|
Jul 15
|
Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling
|
|
Jul 11
|
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
|
|
Jul 11
|
UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR)
|
|
Jul 9
|
1 Value Stock with Impressive Fundamentals and 2 to Turn Down
|
|
Jul 2
|
What's Fueling Tempus AI's Explosive Sales Growth?
|
|
Jun 30
|
United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says
|
|
Jun 28
|
United Therapeutics Announces World’s First Bioengineered External Liver Treatment in Clinical Study
|
|
Jun 27
|
Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?
|
|
Jun 25
|
Does United Therapeutics (NASDAQ:UTHR) Deserve A Spot On Your Watchlist?
|
|
Jun 25
|
5 Must-Read Analyst Questions From United Therapeutics’s Q1 Earnings Call
|
|
Jun 13
|
United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?
|
|
Jun 13
|
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 to Keep Off Your Radar
|
|
Jun 11
|
Insmed Stock Jumps 29% on Encouraging PAH Study Results
|
|
Jun 10
|
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidia
|
|
Jun 10
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
May 27
|
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
|
|
May 14
|
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses
|
|
May 13
|
UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central
|
|
May 11
|
Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?
|